Levofloxacin Patent Expiration

Levofloxacin was first introduced by Janssen Pharmaceuticals Inc in its drug Levaquin on Dec 20, 1996. Other drugs containing Levofloxacin are Levaquin In Dextrose 5% In Plastic Container, Quixin, Iquix. 39 different companies have introduced drugs containing Levofloxacin.


Levofloxacin Patents

Given below is the list of patents protecting Levofloxacin, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Levaquin US6806256

(Pediatric)

Taste masked liquid pharmaceutical compositions Aug 26, 2022

(Expired)

Janssen Pharms
Levaquin US6806256 Taste masked liquid pharmaceutical compositions Feb 26, 2022

(Expired)

Janssen Pharms



Levofloxacin's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Levofloxacin Generic API Manufacturers

Several generic applications have been filed for Levofloxacin. The first generic version for Levofloxacin was by Rising Pharma Holdings Inc and was approved on Dec 20, 2010. And the latest generic version is by Knack Pharmaceuticals Inc and was approved on Jan 29, 2024.

Given below is the list of companies who have filed for Levofloxacin generic, along with the locations of their manufacturing plants worldwide.